Clinical Trial Update: Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a combination of pravastatin and zoledronic acid for Hutchinson-Gilford Progeria Syndrome has completed, according to the la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hutchinson-gilford Progeria Syndrome

Drugs mentioned

• Pravastatin (pravastatin)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Hutchinson-Gilford Progeria Syndrome | Phase 2 | Status: COMPLETED